Duality Advisers’s Myovant Sciences Ltd. MYOV Stock Holding History

Duality Advisers’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54,164	Closed	-$721K	–	919
2022 Q1	$721K	Buy	+54,164	New	+$726K	0.08%	406

Other funds holding MYOV

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Duality Advisers's MYOV Position: Q2 2022 in Review

Duality Advisers sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 54,164 shares — an estimated $721K sold.

Duality Advisers first reported a position in MYOV in Q1 2022 and held it in 1 quarter. The position peaked at $721K in Q1 2022. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

Duality Advisers reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
Duality Advisers sold 54,164 Myovant Sciences Ltd. shares in Q2 2022, an estimated $721K.
Duality Advisers first reported a position in Myovant Sciences Ltd. in Q1 2022 and held it in 1 quarter.
Duality Advisers's Myovant Sciences Ltd. position peaked at $721K in Q1 2022.
91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on Duality Advisers's 13F filing for Q2 2022, filed 8 Aug 2022.